300791 仙乐健康
2024/06 - 中期
人民幣(K¥)
与去年同期
比较
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
2020/12
人民幣(K¥)
营业总收入1,990,47828.85%3,582,0222,507,2622,368,9482,066,818
减:营业总成本1,825,23726.36%3,311,5732,262,8722,111,1621,790,044
    其中:营业成本1,352,62524.11%2,497,9121,725,5571,593,7331,393,012
               财务费用38,497103.02%52,3137,17026,3493,193
               资产减值损失(2,025)-9.68%405(4,977)(2,056)(2,571)
公允价值变动收益2,618-137.52%(57,672)(1,638)(1,046)3,950
投资收益(3,753)-239.60%2,22023,39525,19016,162
    其中:对联营企业和合营企业的投资收益------------
营业利润172,81467.88%282,025265,056289,815315,612
利润总额168,18663.69%273,257251,518280,901311,964
减:所得税费用32,27041.51%32,96939,23349,06654,598
净利润135,91570.01%240,288212,286231,834257,366
减:非控股权益(18,558)-12.63%(40,751)------
股东净利润154,47352.66%281,039212,286231,834257,366

市场价值指针
每股收益 (元) *0.86053.57%1.5591.1791.2881.430
每股派息 (元) *----1.1000.3500.4000.600
每股净资产 (元) *9.028-37.63%12.05313.85013.00518.189
审计意见 #--标准的无保留意见标准的无保留意见标准的无保留意见标准的无保留意见
回页顶
备注: *未调整数据
#只提供简体内容